CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 116.9	$ 131.7
Accounts receivable, less allowance for credit losses of $1.0 and $1.1	159.2	161.9
Contract assets	40.3	45.2
Inventories, net	150.9	153.5
Asbestos-related insurance receivables, current portion	4.3	4.3
Other current assets	29.8	30.3
Total current assets	501.4	526.9
Property, plant and equipment, net of accumulated depreciation of $386.2 and $385.7	363.4	366.3
Operating lease right-of-use assets	18.6	18.9
Goodwill	357.2	359.8
Other intangible assets, net of amortization	120.3	123.9
Asbestos-related insurance receivables, non-current portion	52.2	52.2
Investments in unconsolidated joint ventures	10.9	11.1
Deferred income taxes	55.7	49.7
Other long-term assets	8.3	8.4
Total assets	1,488.0	1,517.2
Current liabilities
Accounts payable	51.7	50.3
Accrued employee benefits and compensation	29.5	31.1
Accrued income taxes payable	7.3	2.0
Operating lease obligations, current portion	3.8	3.5
Asbestos-related liabilities, current portion	$ 5.5	$ 5.5
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other accrued liabilities	Other accrued liabilities
Other accrued liabilities	$ 19.2	$ 24.0
Total current liabilities	117.0	116.4
Borrowings under revolving credit facility	0.0	30.0
Operating lease obligations, non-current portion	15.1	15.4
Asbestos-related liabilities, non-current portion	56.0	56.0
Non-current income tax	7.2	7.2
Deferred income taxes	22.7	22.9
Other long-term liabilities	10.2	10.3
Commitments and contingencies (Note 6 and Note 10)
Shareholders’ equity
Capital stock - $1 par value; 50.0 authorized shares; 18.7 and 18.6 shares issued and outstanding	18.7	18.6
Additional paid-in capital	153.8	151.8
Retained earnings	1,162.8	1,155.0
Accumulated other comprehensive loss	(75.5)	(66.4)
Total shareholders' equity	1,259.8	1,259.0
Total liabilities and shareholders' equity	$ 1,488.0	$ 1,517.2